These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25204716)

  • 1. Astrocytes and microglia but not neurons preferentially generate N-terminally truncated Aβ peptides.
    Oberstein TJ; Spitzer P; Klafki HW; Linning P; Neff F; Knölker HJ; Lewczuk P; Wiltfang J; Kornhuber J; Maler JM
    Neurobiol Dis; 2015 Jan; 73():24-35. PubMed ID: 25204716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amyloid-β₄₂ proxy, amyloid-β(25-35), induces normal human cerebral astrocytes to produce amyloid-β₄₂.
    Dal Prà I; Whitfileld JF; Pacchiana R; Bonafini C; Talacchi A; Chakravarthy B; Armato U; Chiarini A
    J Alzheimers Dis; 2011; 24(2):335-47. PubMed ID: 21258151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease.
    Armato U; Chiarini A; Chakravarthy B; Chioffi F; Pacchiana R; Colarusso E; Whitfield JF; Dal Prà I
    Biochim Biophys Acta; 2013 Oct; 1832(10):1634-52. PubMed ID: 23628734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression Pattern of Scavenger Receptors and Amyloid-β Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer's Disease.
    Eugenín J; Vecchiola A; Murgas P; Arroyo P; Cornejo F; von Bernhardi R
    J Alzheimers Dis; 2016 May; 53(3):857-73. PubMed ID: 27258416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
    Lee M; McGeer E; McGeer PL
    Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease.
    Shinohara M; Koga S; Konno T; Nix J; Shinohara M; Aoki N; Das P; Parisi JE; Petersen RC; Rosenberry TL; Dickson DW; Bu G
    Brain; 2017 Dec; 140(12):3301-3316. PubMed ID: 29161341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.
    Phiel CJ; Wilson CA; Lee VM; Klein PS
    Nature; 2003 May; 423(6938):435-9. PubMed ID: 12761548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of N-terminally truncated pyroglutamate amyloid-β in cholesterol-enriched diet-fed rabbit and AD brain.
    Perez-Garmendia R; Hernandez-Zimbron LF; Morales MA; Luna-Muñoz J; Mena R; Nava-Catorce M; Acero G; Vasilevko V; Viramontes-Pintos A; Cribbs DH; Gevorkian G
    J Alzheimers Dis; 2014; 39(2):441-55. PubMed ID: 24240639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
    Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary: Abeta N- Terminal Isoforms: Critical contributors in the course of AD pathophysiology.
    Tekirian TL
    J Alzheimers Dis; 2001 Apr; 3(2):241-248. PubMed ID: 12214065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
    Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H
    Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival.
    Russo C; Violani E; Salis S; Venezia V; Dolcini V; Damonte G; Benatti U; D'Arrigo C; Patrone E; Carlo P; Schettini G
    J Neurochem; 2002 Sep; 82(6):1480-9. PubMed ID: 12354296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production.
    Strömberg K; Eketjäll S; Georgievska B; Tunblad K; Eliason K; Olsson F; Radesäter AC; Klintenberg R; Arvidsson PI; von Berg S; Fälting J; Cowburn RF; Dabrowski M
    FEBS J; 2015 Jan; 282(1):65-73. PubMed ID: 25303711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro.
    Mulder SD; Nielsen HM; Blankenstein MA; Eikelenboom P; Veerhuis R
    Glia; 2014 Apr; 62(4):493-503. PubMed ID: 24446231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors.
    von Bernhardi R; Eugenín J
    Brain Res; 2004 Oct; 1025(1-2):186-93. PubMed ID: 15464759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin attenuates amyloid beta-induced inflammatory and pro-oxidant responses in astrocytes and microglia.
    Urrutia PJ; Hirsch EC; González-Billault C; Núñez MT
    J Neurochem; 2017 Jul; 142(1):140-152. PubMed ID: 28266714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.